Burden of cardiovascular disease in chronic obstructive pulmonary disease

American Journal of Preventive Medicine

Volumn 47, Issue 2, 2014, Pages 105-114

  Agarwal, Shikhar ^a   Rokadia, Haala ^a   Senn, Todd ^a   Menon, Venu ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DATA ANALYSIS; FEMALE; FRAMINGHAM RISK SCORE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTOR; UNITED STATES; AGED; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; COST OF ILLNESS; NUTRITION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX DIFFERENCE; TIME;

ADULT; AGED; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION SURVEYS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 84904703359     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2014.03.014     Document Type: Article

References (42)

1. I.S. Stone, N.C. Barnes, and S.E. Petersen Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease? Heart 98 14 2012 1055 1062
2. R. Lozano, M. Naghavi, and K. Foreman et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 9859 2012 2095 2128
3. C.J. Murray, A.D. Lopez, and R. Black et al. Global Burden of Disease 2005: call for collaborators Lancet 370 9582 2007 109 110
4. A.D. Lopez, K. Shibuya, and C. Rao et al. Chronic obstructive pulmonary disease: current burden and future projections Eur Respir J 27 2 2006 397 412
5. G.D. Friedman, A.L. Klatsky, and A.B. Siegelaub Lung function and risk of myocardial infarction and sudden cardiac death N Engl J Med 294 20 1976 1071 1075
6. K.L. Ebi-Kryston, V.M. Hawthorne, and G. Rose et al. Breathlessness, chronic bronchitis and reduced pulmonary function as predictors of cardiovascular disease mortality among men in England, Scotland and the U.S Int J Epidemiol 18 1 1989 84 88
7. K.L. Ebi-Kryston Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study J Clin Epidemiol 41 3 1988 251 260
8. A. Gulsvik, V. Hansteen, and E. Sivertssen Cardiac arrhythmias in patients with serious pulmonary diseases Scand J Respir Dis 59 3 1978 154 159
9. E. Bérard, V. Bongard, and N. Roche et al. Undiagnosed airflow limitation in patients at cardiovascular risk Arch Cardiovasc Dis 104 12 2011 619 626
10. A.R. Patel, and J.R. Hurst Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art Expert Rev Respir Med 5 5 2011 647 662
11. GOLD. The Global Initiative for Chronic Obstructive Lung Disease. www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html.
12. S. Sidney, M. Sorel, C.P. Quesenberry Jr, C. DeLuise, S. Lanes, and M.D. Eisner COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program Chest 128 4 2005 2068 2075
13. D.M. Mannino, D. Thorn, A. Swensen, and F. Holguin Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Eur Respir J 32 4 2008 962 969
14. J.R. Feary, L.C. Rodrigues, C.J. Smith, R.B. Hubbard, and J.E. Gibson Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care Thorax 65 11 2010 956 962
15. A.J. van Gestel, M. Kohler, and J. Steier et al. Cardiac autonomic function and cardiovascular response to exercise in patients with chronic obstructive pulmonary disease COPD 9 2 2012 160 165
16. A. van Gestel Jr, and J. Steier Autonomic dysfunction in patients with chronic obstructive pulmonary disease (COPD) J Thorac Dis 2 4 2010 215 222
17. Marma AK, Berry JD, Ning H, Persell SD, Lloyd-Jones DM. Distribution of 10-year and lifetime predicted risks for cardiovascular disease in U.S. adults: findings from the National Health and Nutrition Examination Survey 2003 to 2006. Circ Cardiovasc Qual Outcomes 2010;3(1):8-14.
18. CDC. National Health and Nutrition Examination Survey homepage. www.cdc.gov/nchs/nhanes.htm.
19. J.L. Hankinson, J.R. Odencrantz, and K.B. Fedan Spirometric reference values from a sample of the general U.S. population Am J Respir Crit Care Med 159 1 1999 179 187
20. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. www.goldcopd.org.
21. American Thoracic Society/European Respiratory Society Task Force Standards for the diagnosis and management of patients with COPD. Version 1.2 2004 American Thoracic Society New York www.thoracic.org/clinical/copd- guidelines/resources/copddoc.pdf
22. R.B. D'Agostino Sr, R.S. Vasan, and M.J. Pencina et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 6 2008 743 753
23. Pirkle JL, Flegal KM, Bernert JT, Brody DJ, Etzel RA, Maurer KR. Exposure of the U.S. population to environmental tobacco smoke: the third National Health and Nutrition Examination Survey, 1988 to 1991. JAMA 1996;275(16):1233- 40.
24. A.S. Levey, J. Coresh, and E. Balk et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation classification and stratification Ann Intern Med 139 2 2003 137 147
25. J. Coresh, E. Selvin, and L.A. Stevens et al. Prevalence of chronic kidney disease in the U.S. JAMA 298 17 2007 2038 2047
26. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 14 1997 973 979
27. L.H. Kuller, R.P. Tracy, J. Shaten, and E.N. Meilahn Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial Am J Epidemiol 144 6 1996 537 547
28. L.M. Fabbri, M. Romagnoli, and L. Corbetta et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease Am J Respir Crit Care Med 167 3 2003 418 424
29. V.M. Keatings, and P.J. Barnes Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects Am J Respir Crit Care Med 155 2 1997 449 453
30. A.A. Eid, A.A. Ionescu, and L.S. Nixon et al. Inflammatory response and body composition in chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 8 Pt 1 2001 1414 1418
31. R. Broekhuizen, E.F. Wouters, E.C. Creutzberg, and A.M. Schols Raised CRP levels mark metabolic and functional impairment in advanced COPD Thorax 61 1 2006 17 22
32. M. Saetta, A. Di Stefano, and P. Maestrelli et al. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis Am Rev Respir Dis 147 2 1993 301 306
33. M.I. Schmidt, B.B. Duncan, and A.R. Sharrett et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study Lancet 353 9165 1999 1649 1652
34. S.F. van Eeden, W.C. Tan, and T. Suwa et al. Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM[10]) Am J Respir Crit Care Med 164 5 2001 826 830
35. T. Terashima, B. Wiggs, D. English, J.C. Hogg, and S.F. van Eeden Phagocytosis of small carbon particles (PM10) by alveolar macrophages stimulates the release of polymorphonuclear leukocytes from bone marrow Am J Respir Crit Care Med 155 4 1997 1441 1447
36. S. Andreas, S.D. Anker, P.D. Scanlon, and V.K. Somers Neurohumoral activation as a link to systemic manifestations of chronic lung disease Chest 128 5 2005 3618 3624
37. M. Cazzola, L. Calzetta, and G. Bettoncelli et al. Cardiovascular disease in asthma and COPD: a population-based retrospective cross-sectional study Respir Med 106 2 2012 249 256
38. S. Ben-Zaken Cohen, P.D. Paré, S.F. Man, and D.D. Sin The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism Am J Respir Crit Care Med 176 2 2007 113 120
39. D.D. Sin, S.B. Cohen, A. Day, H. Coxson, and P.D. Paré Understanding the biological differences in susceptibility to chronic obstructive pulmonary disease between men and women Proc Am Thorac Soc 4 8 2007 671 674
40. J.D. Berry, D.M. Lloyd-Jones, D.B. Garside, and P. Greenland Framingham risk score and prediction of coronary heart disease death in young men Am Heart J 154 1 2007 80 86
41. M.W. Cavanaugh-Hussey, J.D. Berry, and D.M. Lloyd-Jones Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool Prev Med 47 6 2008 619 623
42. C. Sibley, R.S. Blumenthal, C.N. Merz, and L. Mosca Limitations of current cardiovascular disease risk assessment strategies in women J Womens Health (Larchmt) 15 1 2006 54 56